![](https://endpts.com/wp-content/uploads/2021/06/mf-FE.jpg)
Biocon slammed with OAI; Hong Kong looks to WuXi for ADC abilities; Tanvex Pharma launches CDMO services
Welcome to Endpoints News’ manufacturing roundup, where we bring you essential updates on new builds, collaborations and more.
This week we saw Biocon Biologics in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.